Structural model of antagonist and agonist binding to the angiotensin II, AT1 subtype, G protein coupled receptor

Chemistry and Biology

Volumn 1, Issue 4, 1994, Pages 211-221

  Underwood, Dennis J ^a   Strader, Catherine D ^b   Rivero, Ralph ^c   Patchett, Arthur A ^d   Greenlee, William ^c   Prendergast, Kristine ^a  

^a Molecular Systems Department   (United States)

^b Molecular Pharmacology and Biochemistry ^*  (United States)

^c Basic Chemistry ^*  (United States)

^d MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Angiotensin II; domain motion; homology models; hypertension; signal transduction

Indexed keywords

RUMEX;

ANGIOTENSIN I; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; AUDIOVISUAL EQUIPMENT; DRUG ANTAGONISM; DRUG POTENTIATION; HUMAN; METABOLISM; MOLECULAR GENETICS;

AMINO ACID SEQUENCE; ANGIOTENSIN I; ANGIOTENSIN II; GTP-BINDING PROTEINS; HUMANS; MODELS, STRUCTURAL; MOLECULAR SEQUENCE DATA; RECEPTORS, ANGIOTENSIN;

EID: 0028674972     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/1074-5521(94)90013-2     Document Type: Article

References (71)

1. Model for the structure of bacteriorhodopsin based on high-resolution electron cryo-microscopy
2. Projection structure of rhodopsin
3. 15N NMR study of the low pH forms of bacteriorhodopsin
4. Determination of membrane protein structure by rotational resonance NR: bacteriorhodopsin
5. This is not a G-protein-coupled receptor
6. The renin angiotensin system
7. Non peptide angiotensin II receptor antagonists
8. Angiotensin-II receptor blockade — an innovative approach to cardiovascular pharmacotherapy
9. 1A receptor
10. 3-dimensional models of G-protein-coupled receptors
11. Ligand-binding domains of G-protein coupled receptors
12. The probable arrangement of the helices in G protein coupled receptors
13. Re-evaluation of bacteriorhodopsin as a model for G-protein-coupled receptors
14. Structure and function of G protein coupled receptors
15. The superfamily: molecular modelling
16. An analysis of the periodicity of conserved residues in sequence alignments of G-protein coupled receptors
17. Characterization of the binding domain of the beta-adrenergic receptor with the fluorescent antagonist carazolol. Evidence for a buried ligand binding site
18. Biophysical and genetic analysis of the ligand-binding site of the β-adrenoceptor
19. Structure of the gene for human beta-2-adrenergic receptor: expression and promoter characterization
20. Cloning and characterization of a human angiotensin II type 1 receptor
21. Localization of agonist and antagonist binding domains of the human neurokinin-1 receptor
22. Cloning and pharmacological characterization of a human bradykinin (BK-2) receptor
23. Molecular cloning of a novel angiotensin II receptor isoform involved in phosphotyrosine phosphatase inhibition.
24. Expression cloning of type 2 angiotensin II receptor reveals a unique class of seven-transmembrane receptors
25. Identification of amino acid residues of rat angiotensin II receptor for ligand binding by site directed mutagenisis
26. Cloning of a B2 bradykinin receptor: examination of the bradykinin binding site by site directed mutagenesis
27. Bradykinin receptors — the effect of mutations on agonist or antagonist binding and the effect on signaling
28. 8]bradykinin)
29. The extracellular domain of the neurokinin-1 receptor is required for high-affinity binding of peptides
30. Characterization of the interaction of N-acyl-l-tryptophan benzyl ester neurokinin antagonists with the human Neurokinin-1 receptor
31. The role of histidine-265 in antagonist binding to the Neurokinin-1 receptor
32. Mapping the ligand-binding site of the NK-1 receptor
33. Ligand-receptor interactions at neurokinin receptors
34. Amino aromatic interaction between histidine-197 of the Neurokinin-1 receptor and CP96345
35. Different binding epitopes on the NK1 receptor for Substance-P and a nonpeptide antagonist
36. Binding epitopes for peptide and nonpeptide ligands on the NK1 (Substance-P) receptor
37. Identification of binding epitopes for nonpeptide antagonists on the tachykinin receptors through construction of chimeric NK-1/NK-2 and NK-1/NK-3 receptors
38. Differentiation between binding-sites for angiotensin-II and nonpeptide antagonists on the antiotensin-II type-1 receptors
39. Interaction of substance P with the second and seventh transmembrane domains of the neurokinin-1 receptor
40. Angiotensin/renin modulators
41. Angiotensin II receptor antagonists: novel heterocycles
42. Effect of covalent dimer conjugates of angiotensin 11 on receptor affinity and activity in vitro
43. 1 selective angiotensin II receptor antagonist
44. Amino-aromatic interactions in proteins
45. Weakly polar interactions in proteins
46. Aromatic rings act as hydrogen bond acceptors
47. Planar stacking interactions of arginine and aromatic side-chains in proteins
48. Acetylcholine binding by a synthetic receptor: implications for biological recognition
49. Structure-activity relationships of nonpeptide angiotensin II receptor antagonists
50. Derivation of a 3D pharmacophore model for the angiotensin-II site one receptor
51. Quinazolinone biphenyl acylsulfonamides — a potent new class of angiotensin-II receptor antagonists
52. The role of position 4 in angiotensin-II antagonism: a structure-activity study
53. A nonpeptide that mimics the biological actions of angiotensin II
54. Functional role of proline and tryptophan residues highly conserved among G - protein coupled receptors studied by mutational analysis of the M3 muscarinic receptor
55. Orientation of retinal in bovine rhodopsin determined by cross-linking using photoactivatable analog of 11-cis-retinal
56. Mapping of the amino acids in membrane-embedded helices that interact with the retinal chromophore in bovine rhodopsin
57. Human growth hormone and extracellular domain of its receptor: crystal structure of the complex
58. Crystal structure of the soluble human 55KD TNF receptor-human TNF-beta complex: Implications for TNF receptor activation
59. The cost of conformational order:entropy changes in molecular associations
60. On the fundamental difference in the thermodynamics of agonist and antagonist interactions with β-adrenergic receptors and the mechanism of entropy driven binding
61. Fundamental differences between the molecular interactions of agonists and antagonists with the (3-adrenergic receptor
62. Reconstitution of functional muscarinic receptors by co-expression of amino and carboxyl terminal receptor fragments
63. Molecular basis of muscarinic acetylcholine receptor function
64. Integration of transmembrane signalling: cross talk among G-protein linked receptors and other signal transduction pathways
65. Mechanisms of multifunctional signalling by G protein linked receptors
66. On the use of the transmembrane domain of bacteriorhodopsin as a template for modeling the three dimensional structure of guanine nucleotide-binding regulatory protein-coupled receptors
67. Sequence homology between bacteriorhodopsin and G-protein coupled receptors: exon shuffling or evolution by duplication?
68. A general method applicable to the search for similarities in the amino acid sequence of two proteins
69. CHARMM: A program for macromolecular energy, minimization, and dynamics calculations
70. The protein data bank: a computer-based archival file for macromolecular structures
71. 1) receptor antagonist